These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23844117)

  • 1. Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.
    Shaffer TL; Balder R; Buskirk SW; Hogan RJ; Lafontaine ER
    PLoS One; 2013; 8(7):e67881. PubMed ID: 23844117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.
    Smidt M; Bättig P; Verhaegh SJ; Niebisch A; Hanner M; Selak S; Schüler W; Morfeldt E; Hellberg C; Nagy E; Lundberg U; Hays JP; Meinke A; Henriques-Normark B
    PLoS One; 2013; 8(5):e64422. PubMed ID: 23671716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development.
    Blakeway LV; Tan A; Peak IRA; Seib KL
    Microbiology (Reading); 2017 Oct; 163(10):1371-1384. PubMed ID: 28893369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling.
    Armbruster CE; Hong W; Pang B; Weimer KE; Juneau RA; Turner J; Swords WE
    mBio; 2010 Jul; 1(3):. PubMed ID: 20802829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.
    Verhaegh SJ; Stol K; de Vogel CP; Riesbeck K; Lafontaine ER; Murphy TF; van Belkum A; Hermans PW; Hays JP
    Clin Vaccine Immunol; 2012 Jun; 19(6):914-8. PubMed ID: 22539468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media.
    Brockson ME; Novotny LA; Jurcisek JA; McGillivary G; Bowers MR; Bakaletz LO
    PLoS One; 2012; 7(6):e40088. PubMed ID: 22768228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.
    Perez AC; Johnson A; Chen Z; Wilding GE; Malkowski MG; Murphy TF
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.
    Ren D; Almudevar AL; Murphy TF; Lafontaine ER; Campagnari AA; Luke-Marshall N; Pichichero ME
    Vaccine; 2019 Jul; 37(32):4637-4645. PubMed ID: 28755833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Respiratory Pathogen Moraxella catarrhalis Targets Collagen for Maximal Adherence to Host Tissues.
    Singh B; Alvarado-Kristensson M; Johansson M; Hallgren O; Westergren-Thorsson G; Mörgelin M; Riesbeck K
    mBio; 2016 Mar; 7(2):e00066. PubMed ID: 27006460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.
    Tan TT; Riesbeck K
    Expert Rev Vaccines; 2007 Dec; 6(6):949-56. PubMed ID: 18377357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.
    Ren D; Almudevar AL; Murphy TF; Lafontaine ER; Campagnari AA; Luke-Marshall N; Casey JR; Pichichero ME
    Vaccine; 2015 Oct; 33(43):5809-5814. PubMed ID: 26392013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.
    Otsuka T; Kirkham C; Johnson A; Jones MM; Murphy TF
    Infect Immun; 2014 Aug; 82(8):3503-12. PubMed ID: 24914218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation.
    Luke NR; Jurcisek JA; Bakaletz LO; Campagnari AA
    Infect Immun; 2007 Dec; 75(12):5559-64. PubMed ID: 17908808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Moraxella catarrhalis phase-variable DNA methyltransferase ModM3 is an epigenetic regulator that affects bacterial survival in an in vivo model of otitis media.
    Blakeway LV; Tan A; Jurcisek JA; Bakaletz LO; Atack JM; Peak IR; Seib KL
    BMC Microbiol; 2019 Dec; 19(1):276. PubMed ID: 31818247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.
    Balder R; Hassel J; Lipski S; Lafontaine ER
    Infect Immun; 2007 Jun; 75(6):2765-75. PubMed ID: 17371858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in children with acute respiratory infection with or without nasopharyngeal bacterial carriage.
    Andrade DC; Borges IC; Bouzas ML; Oliveira JR; Käyhty H; Ruuskanen O; Nascimento-Carvalho C
    Infect Dis (Lond); 2018 Sep; 50(9):705-713. PubMed ID: 29688138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo.
    Perez AC; Pang B; King LB; Tan L; Murrah KA; Reimche JL; Wren JT; Richardson SH; Ghandi U; Swords WE
    Pathog Dis; 2014 Apr; 70(3):280-8. PubMed ID: 24391058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.
    Ruckdeschel EA; Kirkham C; Lesse AJ; Hu Z; Murphy TF
    Infect Immun; 2008 Apr; 76(4):1599-607. PubMed ID: 18227159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.
    Ren D; Yu S; Gao S; Peng D; Petralia RS; Muszynski A; Carlson RW; Robbins JB; Tsai CM; Lim DJ; Gu XX
    Vaccine; 2011 Jun; 29(25):4210-7. PubMed ID: 21501641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.